Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating expenses:
Research and development	$ 2,152	$ 1,800
General and administrative	2,597	651
Total operating expenses	4,749	2,451
Loss from operations	(4,749)	(2,451)
Interest (expense) income, net	20	(13)
Other income (expense), net	(1)
Loss before income taxes	(4,730)	(2,464)
Provision for income taxes	0	0
Net loss	(4,730)	(2,464)
Other comprehensive loss:
Foreign currency translation loss, net of tax	(34)	(2)
Total other comprehensive loss	(34)	(2)
Comprehensive loss	$ (4,764)	$ (2,466)
Loss per share:
Net loss per share, basic and diluted (Note 11)	$ (0.30)	$ (0.48)
Weighted average common shares outstanding:
Basic and diluted	15,670,800	5,166,812